カテゴリー： FactMR, 世界, 医療/バイオ

ペプチド感染症治療薬の世界市場2023年～2033年：予測・動向・分析・競争状況

◆英語タイトル：Peptide-based Infection Therapeutics Market By Drug (Telaprevir, Boceprevir), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), & Region - Global Market Insights 2023 to 2033

FactMRが発行した調査報告書（FACT23AP102）◆商品コード：FACT23AP102
◆発行会社（リサーチ会社）：FactMR
◆発行日：2023年1月19日
◆ページ数：約170
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧、印刷不可）USD4,500 ⇒換算￥684,000見積依頼/購入/質問フォーム
Global Site License（同一拠点内共有可）USD8,500 ⇒換算￥1,292,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ファクトエムアール社の本調査資料は、2023年から2033年までの世界のペプチド感染症治療薬市場の現状・動向について調査した最新レポートです。エグゼクティブサマリー、市場概要、治療薬別（テラプレビル、ボセプレビル）分析、流通チャネル別（病院薬局、小売薬局、オンライン薬局）分析、地域別（北米、中南米、ヨーロッパ、日本、東アジア、南アジア、東南アジア、オセアニア、中東/アフリカ）分析、競争状況・会社概要、調査方法、二次情報源・一次情報源、仮定などの構成でまとめております。なお、当レポートには、Vertex Pharmaceuticals Incorporated、Merck & Co., Inc.、Parchem Fine & Speciality Chemicalsなどの企業情報が含まれています。
・エグゼクティブサマリー
・市場概要
・世界のペプチド感染症治療薬市場規模：治療薬別
　- テラプレビルの市場規模
　- ボセプレビルの市場規模
・世界のペプチド感染症治療薬市場規模：流通チャネル別
　- 病院薬局の市場規模
　- 小売薬局の市場規模
　- オンライン薬局の市場規模
・世界のペプチド感染症治療薬市場規模：地域別
　- 北米のペプチド感染症治療薬市場規模
　- 中南米のペプチド感染症治療薬市場規模
　- ヨーロッパのペプチド感染症治療薬市場規模
　- 日本のペプチド感染症治療薬市場規模
　- 東アジアのペプチド感染症治療薬市場規模
　- 南アジアのペプチド感染症治療薬市場規模
　- 東南アジアのペプチド感染症治療薬市場規模
　- オセアニアのペプチド感染症治療薬市場規模
　- 中東/アフリカのペプチド感染症治療薬市場規模
・競争状況・会社概要
・調査方法
・二次情報源・一次情報源
・仮定

本資料には、各企業の製品ポートフォリオや主要戦略、包括的なSWOT分析などの要素を含む企業情報が含まれています。企業のプレゼンスは、全著名プレーヤーについてマッピングされ、マトリックスを通して提示されます。また、読者に実用的な洞察を提供し、熟考して市場の状況を示し、ペプチド感染症治療薬における競争レベルを推測するのに役立ちます。

Peptide-based Infection Therapeutics Market – Scope of Report

A recent study by Fact.MR on the peptide-based infection therapeutics market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering peptide-based infection therapeutics.

The study also provides the dynamics responsible for influencing the future status of the peptide-based infection therapeutics market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the peptide-based infection therapeutics market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of peptide-based infection therapeutics across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of peptide-based infection therapeutics during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).

Estimates at global and regional levels for peptide-based infection therapeutics are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.

Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global peptide-based infection therapeutics market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the peptide-based infection therapeutics market during the forecast period.

Country-specific valuation on demand for peptide-based infection therapeutics has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading manufacturers of peptide-based infection therapeutics, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering peptide-based infection therapeutics has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the peptide-based infection therapeutics domain.

❖ レポートの目次 ❖

1. Global Market – Executive Summary

2. Global Market Overview

    2.1. Introduction

        2.1.1. Global Market Taxonomy

        2.1.2. Global Market Definition

    2.2. Global Market Size (US$ Mn) and Forecast, 2023-2033

        2.2.1. Global Market Y-o-Y Growth

    2.3. Global Market Dynamics

    2.4. Regulations

    2.5. Supply Chain

    2.6. Cost Structure

    2.7. Average Pricing Analysis

    2.8. Epidemiology

    2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Market Analysis and Forecast By Drug

    3.1. Global Market Size and Forecast By Drug, 2023-2033

        3.1.1. Telaprevir Market Size and Forecast, 2023-2033

            3.1.1.1. Revenue (US$ Mn) Comparison, By Region

            3.1.1.2. Market Share Comparison, By Region

            3.1.1.3. Y-o-Y growth Comparison, By Region

        3.1.2. Boceprevir Market Size and Forecast, 2023-2033

            3.1.2.1. Revenue (US$ Mn) Comparison, By Region

            3.1.2.2. Market Share Comparison, By Region

            3.1.2.3. Y-o-Y growth Comparison, By Region

4. Global Market Analysis and Forecast By Distribution Channel

    4.1. Global Market Size and Forecast By Distribution Channel, 2023-2033

        4.1.1. Hospital Pharmacies Market Size and Forecast, 2023-2033

            4.1.1.1. Revenue (US$ Mn) Comparison, By Region

            4.1.1.2. Market Share Comparison, By Region

            4.1.1.3. Y-o-Y growth Comparison, By Region

        4.1.2. Retail Pharmacies Market Size and Forecast, 2023-2033

            4.1.2.1. Revenue (US$ Mn) Comparison, By Region

            4.1.2.2. Market Share Comparison, By Region

            4.1.2.3. Y-o-Y growth Comparison, By Region

        4.1.3. Online Pharmacies Market Size and Forecast, 2023-2033

            4.1.3.1. Revenue (US$ Mn) Comparison, By Region

            4.1.3.2. Market Share Comparison, By Region

            4.1.3.3. Y-o-Y growth Comparison, By Region

5. Global Market Analysis and Forecast By Region

    5.1. Global Market Size and Forecast, 2023-2033

        5.1.1. North America Market Size and Forecast, 2023-2033

            5.1.1.1. Revenue (US$ Mn) Comparison, By Drug

            5.1.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

        5.1.2. Latin America Market Size and Forecast, 2023-2033

            5.1.2.1. Revenue (US$ Mn) Comparison, By Drug

            5.1.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel

        5.1.3. Europe Market Size and Forecast, 2023-2033

            5.1.3.1. Revenue (US$ Mn) Comparison, By Drug

            5.1.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel

        5.1.4. Japan Market Size and Forecast, 2023-2033

            5.1.4.1. Revenue (US$ Mn) Comparison, By Drug

            5.1.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel

        5.1.5. APEJ Market Size and Forecast, 2023-2033

            5.1.5.1. Revenue (US$ Mn) Comparison, By Drug

            5.1.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel

        5.1.6. MEA Market Size and Forecast, 2023-2033

            5.1.6.1. Revenue (US$ Mn) Comparison, By Drug

            5.1.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel

6. North America Market Analysis and Forecast, By Country, 2023-2033

    6.1. US Market Size and Forecast, 2023-2033

        6.1.1. Revenue (US$ Mn) Comparison, By Drug

        6.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    6.2. Canada Market Size and Forecast, 2023-2033

        6.2.1. Revenue (US$ Mn) Comparison, By Drug

        6.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel

7. Latin America Market Analysis and Forecast, By Country, 2023-2033

    7.1. Brazil Market Size and Forecast, 2023-2033

        7.1.1. Revenue (US$ Mn) Comparison, By Drug

        7.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    7.2. Mexico Market Size and Forecast, 2023-2033

        7.2.1. Revenue (US$ Mn) Comparison, By Drug

        7.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    7.3. Argentina Market Size and Forecast, 2023-2033

        7.3.1. Revenue (US$ Mn) Comparison, By Drug

        7.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel

8. Europe Market Analysis and Forecast, By Country, 2023-2033

    8.1. Germany Market Size and Forecast, 2023-2033

        8.1.1. Revenue (US$ Mn) Comparison, By Drug

        8.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    8.2. UK Market Size and Forecast, 2023-2033

        8.2.1. Revenue (US$ Mn) Comparison, By Drug

        8.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    8.3. France Market Size and Forecast, 2023-2033

        8.3.1. Revenue (US$ Mn) Comparison, By Drug

        8.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    8.4. Spain Market Size and Forecast, 2023-2033

        8.4.1. Revenue (US$ Mn) Comparison, By Drug

        8.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    8.5. Italy Market Size and Forecast, 2023-2033

        8.5.1. Revenue (US$ Mn) Comparison, By Drug

        8.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    8.6. Nordic Market Size and Forecast, 2023-2033

        8.6.1. Revenue (US$ Mn) Comparison, By Drug

        8.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel

9. Japan Market Analysis and Forecast, By Country, 2023-2033

    9.1. Japan Market Size and Forecast, 2023-2033

        9.1.1. Revenue (US$ Mn) Comparison, By Drug

        9.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

10. APEJ Market Analysis and Forecast, By Country, 2023-2033

    10.1. China Market Size and Forecast, 2023-2033

        10.1.1. Revenue (US$ Mn) Comparison, By Drug

        10.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    10.2. India Market Size and Forecast, 2023-2033

        10.2.1. Revenue (US$ Mn) Comparison, By Drug

        10.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    10.3. Malaysia Market Size and Forecast, 2023-2033

        10.3.1. Revenue (US$ Mn) Comparison, By Drug

        10.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    10.4. Thailand Market Size and Forecast, 2023-2033

        10.4.1. Revenue (US$ Mn) Comparison, By Drug

        10.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    10.5. Singapore Market Size and Forecast, 2023-2033

        10.5.1. Revenue (US$ Mn) Comparison, By Drug

        10.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    10.6. Australia Market Size and Forecast, 2023-2033

        10.6.1. Revenue (US$ Mn) Comparison, By Drug

        10.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel

11. MEA Market Analysis and Forecast, By Country, 2023-2033

    11.1. GCC Countries Market Size and Forecast, 2023-2033

        11.1.1. Revenue (US$ Mn) Comparison, By Drug

        11.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    11.2. South Africa Market Size and Forecast, 2023-2033

        11.2.1. Revenue (US$ Mn) Comparison, By Drug

        11.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    11.3. Nigeria Market Size and Forecast, 2023-2033

        11.3.1. Revenue (US$ Mn) Comparison, By Drug

        11.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    11.4. Israel Market Size and Forecast, 2023-2033

        11.4.1. Revenue (US$ Mn) Comparison, By Drug

        11.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel

12. Global Market Competition Landscape and Company Profile

    12.1. Company Share Analysis By Region

        12.1.1. Vertex Pharmaceuticals Incorporated

            12.1.1.1. Company Overview

            12.1.1.2. Market Drug list

            12.1.1.3. Market Drug Sales Data and Key Financials

            12.1.1.4. Key Developments

            12.1.1.5. SWOT Analysis

        12.1.2. Merck & Co., Inc.

            12.1.2.1. Company Overview

            12.1.2.2. Market Drug list

            12.1.2.3. Market Drug Sales Data and Key Financials

            12.1.2.4. Key Developments

            12.1.2.5. SWOT Analysis

        12.1.3. Parchem Fine & Speciality Chemicals

            12.1.3.1. Company Overview

            12.1.3.2. Market Drug list

            12.1.3.3. Market Drug Sales Data and Key Financials

            12.1.3.4. Key Developments

            12.1.3.5. SWOT Analysis

13. Research Methodology

14. Secondary and Primary Sources

15. Assumptions and Acronyms

16. Disclaimer

TABLE 01: Global Market Value (US$ Mn), 2018-2022

TABLE 02: Global Market Value (US$ Mn), 2023-2033

TABLE 03: Global Market Value (US$ Mn) and Y-o-Y, 2023-2033

TABLE 04: Global Telaprevir Segment Value (US$ Mn), By Region 2018-2022

TABLE 05: Global Telaprevir Segment Value (US$ Mn), By Region 2023-2033

TABLE 06: Global Telaprevir Segment Market Share, By Region 2018-2022

TABLE 07: Global Telaprevir Segment Market Share, By Region 2023-2033

TABLE 08: Global Telaprevir Segment Y-o-Y, By Region 2023-2033

TABLE 09: Global Boceprevir Segment Value (US$ Mn), By Region 2018-2022

TABLE 10: Global Boceprevir Segment Value (US$ Mn), By Region 2023-2033

TABLE 11: Global Boceprevir Segment Market Share, By Region 2018-2022

TABLE 12: Global Boceprevir Segment Market Share, By Region 2023-2033

TABLE 13: Global Boceprevir Segment Y-o-Y, By Region 2023-2033

TABLE 14: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2022

TABLE 15: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2023-2033

TABLE 16: Global Hospital Pharmacies Segment Market Share, By Region 2018-2022

TABLE 17: Global Hospital Pharmacies Segment Market Share, By Region 2023-2033

TABLE 18: Global Hospital Pharmacies Segment Y-o-Y, By Region 2023-2033

TABLE 19: Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2022

TABLE 20: Global Retail Pharmacies Segment Value (US$ Mn), By Region 2023-2033

TABLE 21: Global Retail Pharmacies Segment Market Share, By Region 2018-2022

TABLE 22: Global Retail Pharmacies Segment Market Share, By Region 2023-2033

TABLE 23: Global Retail Pharmacies Segment Y-o-Y, By Region 2023-2033

TABLE 24: Global Online Pharmacies Segment Value (US$ Mn), By Region 2018-2022

TABLE 25: Global Online Pharmacies Segment Value (US$ Mn), By Region 2023-2033

TABLE 26: Global Online Pharmacies Segment Market Share, By Region 2018-2022

TABLE 27: Global Online Pharmacies Segment Market Share, By Region 2023-2033

TABLE 28: Global Online Pharmacies Segment Y-o-Y, By Region 2023-2033

TABLE 29: North America Market Value (US$ Mn), By Drug 2018-2022

TABLE 30: North America Market Value (US$ Mn), By Drug 2023-2033

TABLE 31: North America Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 32: North America Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 33: Latin America Market Value (US$ Mn), By Drug 2018-2022

TABLE 34: Latin America Market Value (US$ Mn), By Drug 2023-2033

TABLE 35: Latin America Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 36: Latin America Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 37: Europe Market Value (US$ Mn), By Drug 2018-2022

TABLE 38: Europe Market Value (US$ Mn), By Drug 2023-2033

TABLE 39: Europe Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 40: Europe Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 41: Japan Market Value (US$ Mn), By Drug 2018-2022

TABLE 42: Japan Market Value (US$ Mn), By Drug 2023-2033

TABLE 43: Japan Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 44: Japan Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 45: APEJ Market Value (US$ Mn), By Drug 2018-2022

TABLE 46: APEJ Market Value (US$ Mn), By Drug 2023-2033

TABLE 47: APEJ Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 48: APEJ Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 49: MEA Market Value (US$ Mn), By Drug 2018-2022

TABLE 50: MEA Market Value (US$ Mn), By Drug 2023-2033

TABLE 51: MEA Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 52: MEA Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 53: US Market Value (US$ Mn), By Drug 2018-2022

TABLE 54: US Market Value (US$ Mn), By Drug 2023-2033

TABLE 55: US Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 56: US Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 57: Canada Market Value (US$ Mn), By Drug 2018-2022

TABLE 58: Canada Market Value (US$ Mn), By Drug 2023-2033

TABLE 59: Canada Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 60: Canada Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 61: Brazil Market Value (US$ Mn), By Drug 2018-2022

TABLE 62: Brazil Market Value (US$ Mn), By Drug 2023-2033

TABLE 63: Brazil Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 64: Brazil Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 65: Mexico Market Value (US$ Mn), By Drug 2018-2022

TABLE 66: Mexico Market Value (US$ Mn), By Drug 2023-2033

TABLE 67: Mexico Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 68: Mexico Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 69: Argentina Market Value (US$ Mn), By Drug 2018-2022

TABLE 70: Argentina Market Value (US$ Mn), By Drug 2023-2033

TABLE 71: Argentina Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 72: Argentina Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 73: Germany Market Value (US$ Mn), By Drug 2018-2022

TABLE 74: Germany Market Value (US$ Mn), By Drug 2023-2033

TABLE 75: Germany Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 76: Germany Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 77: UK Market Value (US$ Mn), By Drug 2018-2022

TABLE 78: UK Market Value (US$ Mn), By Drug 2023-2033

TABLE 79: UK Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 80: UK Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 81: France Market Value (US$ Mn), By Drug 2018-2022

TABLE 82: France Market Value (US$ Mn), By Drug 2023-2033

TABLE 83: France Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 84: France Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 85: Spain Market Value (US$ Mn), By Drug 2018-2022

TABLE 86: Spain Market Value (US$ Mn), By Drug 2023-2033

TABLE 87: Spain Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 88: Spain Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 89: Italy Market Value (US$ Mn), By Drug 2018-2022

TABLE 90: Italy Market Value (US$ Mn), By Drug 2023-2033

TABLE 91: Italy Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 92: Italy Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 93: Nordic Market Value (US$ Mn), By Drug 2018-2022

TABLE 94: Nordic Market Value (US$ Mn), By Drug 2023-2033

TABLE 95: Nordic Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 96: Nordic Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 97: Japan Market Value (US$ Mn), By Drug 2018-2022

TABLE 98: Japan Market Value (US$ Mn), By Drug 2023-2033

TABLE 99: Japan Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 100: Japan Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 101: China Market Value (US$ Mn), By Drug 2018-2022

TABLE 102: China Market Value (US$ Mn), By Drug 2023-2033

TABLE 103: China Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 104: China Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 105: India Market Value (US$ Mn), By Drug 2018-2022

TABLE 106: India Market Value (US$ Mn), By Drug 2023-2033

TABLE 107: India Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 108: India Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 109: Malaysia Market Value (US$ Mn), By Drug 2018-2022

TABLE 110: Malaysia Market Value (US$ Mn), By Drug 2023-2033

TABLE 111: Malaysia Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 112: Malaysia Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 113: Thailand Market Value (US$ Mn), By Drug 2018-2022

TABLE 114: Thailand Market Value (US$ Mn), By Drug 2023-2033

TABLE 115: Thailand Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 116: Thailand Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 117: Singapore Market Value (US$ Mn), By Drug 2018-2022

TABLE 118: Singapore Market Value (US$ Mn), By Drug 2023-2033

TABLE 119: Singapore Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 120: Singapore Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 121: Australia Market Value (US$ Mn), By Drug 2018-2022

TABLE 122: Australia Market Value (US$ Mn), By Drug 2023-2033

TABLE 123: Australia Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 124: Australia Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 125: GCC Countries Market Value (US$ Mn), By Drug 2018-2022

TABLE 126: GCC Countries Market Value (US$ Mn), By Drug 2023-2033

TABLE 127: GCC Countries Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 128: GCC Countries Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 129: South Africa Market Value (US$ Mn), By Drug 2018-2022

TABLE 130: South Africa Market Value (US$ Mn), By Drug 2023-2033

TABLE 131: South Africa Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 132: South Africa Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 133: Nigeria Market Value (US$ Mn), By Drug 2018-2022

TABLE 134: Nigeria Market Value (US$ Mn), By Drug 2023-2033

TABLE 135: Nigeria Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 136: Nigeria Market Value (US$ Mn), By Distribution Channel 2023-2033

TABLE 137: Israel Market Value (US$ Mn), By Drug 2018-2022

TABLE 138: Israel Market Value (US$ Mn), By Drug 2023-2033

TABLE 139: Israel Market Value (US$ Mn), By Distribution Channel 2018-2022

TABLE 140: Israel Market Value (US$ Mn), By Distribution Channel 2023-2033

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ペプチド感染症治療薬の世界市場2023年～2033年：予測・動向・分析・競争状況(Peptide-based Infection Therapeutics Market By Drug (Telaprevir, Boceprevir), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), & Region - Global Market Insights 2023 to 2033)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ペプチドベース心臓血管治療薬の世界市場2023年-2033年：予測・動向・分析・競争状況
  • ペプチド治療薬（メタボリックシンドローム用）の世界市場2023年～2033年：予測・動向・分析・競争状況
  • プレフィルドオートインジェクター（薬剤充填済み自動注射器）の世界市場2023年～2033年：予測・動向・分析・競争状況
  • 細胞株開発の世界市場2023年-2033年：予測・動向・分析・競争状況
  • 小児医療用OTC医薬品の世界市場2023年-2033年：予測・動向・分析・競争状況

    • ◆H&Iグローバルリサーチのお客様（例）◆